Advance Glycoscience Research Cluster, National University of Ireland Galway, H91 W2TY Galway, Ireland.
Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan.
Int J Mol Sci. 2020 Dec 31;22(1):349. doi: 10.3390/ijms22010349.
In recent years, it has been realized that the tau protein is a key player in multiple neurodegenerative diseases. Positron emission tomography (PET) radiotracers that bind to tau filaments in Alzheimer's disease (AD) are in common use, but PET tracers binding to tau filaments of rarer, age-related dementias, such as Pick's disease, have not been widely explored. To design disease-specific and tau-selective PET tracers, it is important to determine where and how PET tracers bind to tau filaments. In this paper, we present the first molecular modelling study on PET probe binding to the structured core of tau filaments from a patient with Pick's disease (Tau). We have used docking, molecular dynamics simulations, binding-affinity and tunnel calculations to explore Tau binding sites, binding modes, and binding energies of PET probes (AV-1451, MK-6240, PBB3, PM-PBB3, THK-5351 and PiB) with Tau. The probes bind to Tau at multiple surface binding sites as well as in a cavity binding site. The probes show unique surface binding patterns, and, out of them all, PM-PBB3 proves to bind the strongest. The findings suggest that our computational workflow of structural and dynamic details of the tau filaments has potential for the rational design of Tau specific PET tracers.
近年来,人们已经意识到 tau 蛋白是多种神经退行性疾病的关键因素。正电子发射断层扫描 (PET) 放射性示踪剂可与阿尔茨海默病 (AD) 中的 tau 纤维结合,目前已广泛应用,但与 Pick 病等罕见、与年龄相关的痴呆症的 tau 纤维结合的 PET 示踪剂尚未得到广泛探索。为了设计针对特定疾病和 tau 蛋白的 PET 示踪剂,确定 PET 示踪剂与 tau 纤维结合的位置和方式非常重要。在本文中,我们首次对来自 Pick 病患者的 tau 纤维的结构核心与 PET 探针结合进行了分子建模研究(Tau)。我们使用对接、分子动力学模拟、结合亲和力和隧道计算来探索 Tau 结合位点、结合模式和 PET 探针(AV-1451、MK-6240、PBB3、PM-PBB3、THK-5351 和 PiB)与 Tau 的结合能。探针可与 Tau 上的多个表面结合位点以及腔内结合位点结合。探针显示出独特的表面结合模式,其中 PM-PBB3 被证明具有最强的结合能力。这些发现表明,我们对 tau 纤维结构和动态细节的计算工作流程具有合理设计 Tau 特异性 PET 示踪剂的潜力。